Skip to content

Project IMPACT: Improving Memory Performance by Applying Cognitive Training

Cognitive Training to Reduce Impulsivity in HIV-infected Cocaine Users

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02909101
Enrollment
58
Registered
2016-09-21
Start date
2017-03-01
Completion date
2019-02-23
Last updated
2019-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine Use Disorders, HIV

Keywords

Working memory, cognitive training, HIV, substance abuse

Brief summary

The purpose of this study is to examine the effects of a cognitive training program in persons with Human Immunodeficiency Virus (HIV) infection who have used cocaine. This study tests the feasibility and preliminary efficacy of a computerized cognitive training program to improve working memory and decrease impulsivity (delay discounting) among HIV-infected individuals.

Detailed description

Of the 1.2 million Americans living with HIV, over half experience neurocognitive impairments (NCI) that adversely affect daily living and are predictive of increased morbidity and mortality. HIV-infected individuals who are addicted to stimulant drugs like cocaine are at even higher risk for NCI, which contributes to impulsive decision making, and engage in high rates of risky behaviors that are associated with both poor clinical outcomes and HIV transmission to others. Delay discounting, a key aspect of impulsivity, describes the tendency to devalue a reward as the delay to its receipt increases. Individuals addicted to drugs tend to prefer smaller, immediate rewards over larger, delayed rewards. Excessive discounting is associated with a wide range of other health risk behaviors, including risky sex. The Competing Neurobehavioral Decision Systems model posits that excessive discounting results from greater relative strength of the impulsive system over the executive control system. The investigators' own work suggests that HIV infection modulates the effect of cocaine on brain functioning in the executive control network during delay discounting. Prior research supports a robust association between excessive discounting and working memory impairment. As a core executive function that supports self-regulation, working memory is theoretically an intervention target for HIV risk reduction. Computerized working memory training has been shown to decrease delay discounting in stimulant users, but it has not yet been tested in HIV-infected drug users. The proposed R21 study will test the preliminary efficacy of a computerized cognitive training program to improve working memory and reduce delay discounting in HIV-infected cocaine users. Using a randomized trial design, the investigators will assign 50 participants to either the experimental cognitive training condition or an attention-matched control condition. Participants will complete 48 sessions in 8 weeks, with assessments at baseline, post-training, and 1-month follow-up to evaluate intervention effects. The investigators hypothesize that cognitive training will, relative to the control condition, lead to greater improvements in working memory and reductions in delay discounting. The investigators will also examine change in HIV risk behaviors (cocaine use, risky sex, and medication adherence). Results will support an R01 application for a larger scale trial to rigorously test the impact of cognitive training on HIV-related behavioral and clinical outcomes. This innovative line of research has important translational implications for HIV clinical practice, including dissemination in resource-limited settings with few neuropsychology specialists. This proposal directly advances a high priority topic for AIDS-designated funding by testing a novel treatment for HIV-associated NCI in drug users. By focusing on a high-risk population that continues to drive HIV transmission, this research has strong potential to improve neurobehavioral functioning in HIV-infected persons, and ultimately to reduce the incidence of new HIV infections.

Interventions

Cognitive training games

DEVICEControl Training (CON)

Cognitive training games

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* HIV infection * currently on antiretroviral medications for \>3 months * cocaine use as defined by crack/cocaine use in the past month, cocaine-type stimulant use disorder, and cocaine as the principal substance of abuse * working memory impairment as defined by scoring \>1 standard deviation below the normative mean on at least 2 out of the 3 working memory tests

Exclusion criteria

* pregnancy * English non-fluency or illiteracy * \<8th grade education * serious neurological disorders including HIV dementia, traumatic brain injury, severe mental illness, or acute psychiatric distress * impaired mental status * individuals who state they are planning to move away from the area within the next 3 months * individuals without stable housing

Design outcomes

Primary

MeasureTime frameDescription
Working Memory Assessed by Domain Deficit ScoreBaseline; post-training, approximately 8 weeksMeasured by domain deficit score, which is a continuous measure of overall impairment on the domain. 0 means no impairment and 5 means highest possible impairment.

Secondary

MeasureTime frameDescription
Acceptability as Measured by Participant RatingsPost-training, approximately 8 weeksParticipants rated how satisfied they found the intervention on a 5 point scale (with 1 being very dissatisfied and 5 being very satisfied). Acceptability was defined a priori of achieving a mean rating of \>3.5 on the 5 point scale.
Acceptability as Measured by Participant Perception of Benefits and Barriers to Completing SessionsPost-training, approximately 8 weeksParticipants rated how helpful they found the intervention on a 5 point scale (with 1 being very unhelpful and 5 being very helpful). Acceptability was defined a priori of achieving a mean rating of \>3.5 on the 5 point scale for helpfulness.
Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)Baseline; post-training, approximately 8 weeksThe Monetary Choice Questionnaire (MCQ) is a standardized delay discounting task. Because scores are on a logarithmic scale, they were rank ordered for analysis. Ranks range from 1 to 13, with higher ranks meaning higher impulsivity.
Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)Baseline; post-training, approximately 8 weeksThe RAB is a standardized survey. Scores range from 0 to 18, with higher scores meaning greater sexual risk.
Number of Days of Cocaine Use as Measured by Timeline Followback Interview MethodologyBaseline; post-training, approximately 8 weeksThe Timeline Followback Method involves asking subjects to retrospectively estimate their cocaine use 30 days prior to the interview date. Responses therefore range from 0 to 30 days.
Percent Medication Adherence Across All Antiretroviral MedicationsBaseline; post-training, approximately 8 weeks0% indicates no doses of medications were taken, and 100% means all doses were taken.

Countries

United States

Participant flow

Participants by arm

ArmCount
Active Cognitive Training (ACT)
Participants will complete computerized games designed to enhance working memory. Participants will complete 48 training sessions over 10 weeks. Active Cognitive Training (ACT): Cognitive training games
29
Control Training (CON)
Participants will complete 48 training sessions over 10 weeks. The control games are not designed to enhance memory. Control Training (CON): Cognitive training games
29
Total58

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11

Baseline characteristics

CharacteristicTotalActive Cognitive Training (ACT)Control Training (CON)
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
58 Participants29 Participants29 Participants
Age, Continuous48.62 years
STANDARD_DEVIATION 9.15
48.97 years
STANDARD_DEVIATION 10.09
48.28 years
STANDARD_DEVIATION 8.28
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
58 Participants29 Participants29 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
50 Participants26 Participants24 Participants
Race (NIH/OMB)
More than one race
3 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
4 Participants1 Participants3 Participants
Region of Enrollment
United States
58 Participants29 Participants29 Participants
Sex: Female, Male
Female
17 Participants5 Participants12 Participants
Sex: Female, Male
Male
41 Participants24 Participants17 Participants
Wechsler Test of Adult Reading (WTAR)82.55 units on a scale
STANDARD_DEVIATION 14
81.97 units on a scale
STANDARD_DEVIATION 14.47
83.14 units on a scale
STANDARD_DEVIATION 13.75

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 29
other
Total, other adverse events
0 / 290 / 29
serious
Total, serious adverse events
0 / 290 / 29

Outcome results

Primary

Working Memory Assessed by Domain Deficit Score

Measured by domain deficit score, which is a continuous measure of overall impairment on the domain. 0 means no impairment and 5 means highest possible impairment.

Time frame: Baseline; post-training, approximately 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Active Cognitive Training (ACT)Working Memory Assessed by Domain Deficit ScoreBaseline.29 Score on a scaleStandard Error 0.09
Active Cognitive Training (ACT)Working Memory Assessed by Domain Deficit ScorePost-training.14 Score on a scaleStandard Error 0.07
Control Training (CON)Working Memory Assessed by Domain Deficit ScoreBaseline.21 Score on a scaleStandard Error 0.09
Control Training (CON)Working Memory Assessed by Domain Deficit ScorePost-training.26 Score on a scaleStandard Error 0.07
Comparison: Estimated marginal means, adjusted for covariates in the model, are reported. The p-value reported is for the Arm by Time interaction effect.p-value: 0.039ANCOVA
Secondary

Acceptability as Measured by Participant Perception of Benefits and Barriers to Completing Sessions

Participants rated how helpful they found the intervention on a 5 point scale (with 1 being very unhelpful and 5 being very helpful). Acceptability was defined a priori of achieving a mean rating of \>3.5 on the 5 point scale for helpfulness.

Time frame: Post-training, approximately 8 weeks

ArmMeasureValue (MEAN)Dispersion
Active Cognitive Training (ACT)Acceptability as Measured by Participant Perception of Benefits and Barriers to Completing Sessions4.14 score on a scaleStandard Deviation 1.15
Control Training (CON)Acceptability as Measured by Participant Perception of Benefits and Barriers to Completing Sessions4.04 score on a scaleStandard Deviation 1.02
Comparison: To determine acceptability in terms of helpfulness, we examined whether mean ratings for both arms were above 3.5, and we also examined whether there was any difference between arms.p-value: 0.719t-test, 2 sided
Secondary

Acceptability as Measured by Participant Ratings

Participants rated how satisfied they found the intervention on a 5 point scale (with 1 being very dissatisfied and 5 being very satisfied). Acceptability was defined a priori of achieving a mean rating of \>3.5 on the 5 point scale.

Time frame: Post-training, approximately 8 weeks

ArmMeasureValue (MEAN)Dispersion
Active Cognitive Training (ACT)Acceptability as Measured by Participant Ratings4.04 score on a scaleStandard Deviation 1.32
Control Training (CON)Acceptability as Measured by Participant Ratings4.14 score on a scaleStandard Deviation 1.11
Comparison: To determine acceptability, we examined whether mean ratings for both arms were above 3.5, and we also examined whether there was any difference between arms.p-value: 0.744t-test, 2 sided
Secondary

Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)

The Monetary Choice Questionnaire (MCQ) is a standardized delay discounting task. Because scores are on a logarithmic scale, they were rank ordered for analysis. Ranks range from 1 to 13, with higher ranks meaning higher impulsivity.

Time frame: Baseline; post-training, approximately 8 weeks

Population: One participant from ACT and two participants from CON were excluded because they did not provide valid responses on the MCQ at the post-training follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Active Cognitive Training (ACT)Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)Baseline8.70 score on a scaleStandard Error 0.41
Active Cognitive Training (ACT)Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)Post-training8.38 score on a scaleStandard Error 0.37
Control Training (CON)Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)Baseline7.97 score on a scaleStandard Error 0.42
Control Training (CON)Delay Discounting, Measured by the Monetary Choice Questionnaire (MCQ)Post-training8.76 score on a scaleStandard Error 0.38
Comparison: Estimated marginal means, adjusted for covariates in the model, are reported. The p-value reported is for the Arm by Time interaction effect.p-value: 0.054ANCOVA
Secondary

Number of Days of Cocaine Use as Measured by Timeline Followback Interview Methodology

The Timeline Followback Method involves asking subjects to retrospectively estimate their cocaine use 30 days prior to the interview date. Responses therefore range from 0 to 30 days.

Time frame: Baseline; post-training, approximately 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Active Cognitive Training (ACT)Number of Days of Cocaine Use as Measured by Timeline Followback Interview MethodologyBaseline7.51 daysStandard Error 1.68
Active Cognitive Training (ACT)Number of Days of Cocaine Use as Measured by Timeline Followback Interview MethodologyPost-training8.49 daysStandard Error 1.72
Control Training (CON)Number of Days of Cocaine Use as Measured by Timeline Followback Interview MethodologyBaseline6.88 daysStandard Error 1.68
Control Training (CON)Number of Days of Cocaine Use as Measured by Timeline Followback Interview MethodologyPost-training5.12 daysStandard Error 1.72
Comparison: Estimated marginal means, adjusted for covariates in the model, are reported. The p-value reported is for the Arm by Time interaction effect.p-value: 0.133ANCOVA
Secondary

Percent Medication Adherence Across All Antiretroviral Medications

0% indicates no doses of medications were taken, and 100% means all doses were taken.

Time frame: Baseline; post-training, approximately 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Active Cognitive Training (ACT)Percent Medication Adherence Across All Antiretroviral MedicationsBaseline96.53 percentage of dosesStandard Error 2.29
Active Cognitive Training (ACT)Percent Medication Adherence Across All Antiretroviral MedicationsPost-training96.08 percentage of dosesStandard Error 2.19
Control Training (CON)Percent Medication Adherence Across All Antiretroviral MedicationsBaseline88.97 percentage of dosesStandard Error 2.29
Control Training (CON)Percent Medication Adherence Across All Antiretroviral MedicationsPost-training92.03 percentage of dosesStandard Error 2.19
Comparison: Estimated marginal means, adjusted for covariates in the model, are reported. The p-value reported is for the Arm by Time interaction effect.p-value: 0.337ANCOVA
Secondary

Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)

The RAB is a standardized survey. Scores range from 0 to 18, with higher scores meaning greater sexual risk.

Time frame: Baseline; post-training, approximately 8 weeks

ArmMeasureGroupValue (MEAN)Dispersion
Active Cognitive Training (ACT)Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)Post-training4.04 score on a scaleStandard Error 0.47
Active Cognitive Training (ACT)Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)Baseline4.53 score on a scaleStandard Error 0.43
Control Training (CON)Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)Baseline3.68 score on a scaleStandard Error 0.43
Control Training (CON)Sexual Risk Behavior as Measured by the Risk Assessment Battery (RAB)Post-training4.21 score on a scaleStandard Error 0.47
Comparison: Estimated marginal means, adjusted for covariates in the model, are reported. The p-value reported is for the Arm by Time interaction effect.p-value: 0.025ANCOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026